Tissue microarray validation
نویسندگان
چکیده
منابع مشابه
Validation of tissue microarray technology in vulvar cancer.
The aim of the study was to validate tissue microarray (TMA) for vulvar cancer by comparing immunohistochemical staining results of triplicate core biopsies on TMA with the results of full section analysis. The study material consisted of slides and selected tissue blocks from 40 patients with vulvar cancer. A TMA was constructed with 3 cores/case. Both the TMA and the slides were stained with ...
متن کاملExperimental Validation of Microarray Data
In this chapter, we describe a few popular experimental methodologies that can be used to independently validate the results of a microarray experiment. In contrast to many of the other chapters in this book, the techniques described here are decidedly non-mathematical or statistical in nature. Instead, most of them utilize standard 'wet-bench' molecular biology protocols that have proven thems...
متن کاملDemystified...tissue microarray technology.
Several "high throughput methods" have been introduced into research and routine laboratories during the past decade. Providing a new approach to the analysis of genomic alterations and RNA or protein expression patterns, these new techniques generate a plethora of new data in a relatively short time, and promise to deliver clues to the diagnosis and treatment of human cancer. Along with these ...
متن کاملTissue microarray validation: a methodologic study with special reference to lung cancer.
BACKGROUND Although tissue microarray (TMA) studies of histopathologic material have been frequently reported in studies of malignant diseases, the question of sample size (i.e., the diameter and the number of tissue cylinders investigated) has been rarely discussed. This study addresses the methodologic question of sample size in a variety of tumor types. MATERIAL AND METHODS Material from 2...
متن کاملUse of tissue microarray for interlaboratory validation of HER2 immunocytochemical and FISH testing.
AIMS To evaluate the use of tissue microarray (TMA) technology as a validation tool for HER2 testing by both immunocytochemistry (ICC) and fluorescence in situ hybridisation (FISH) in the diagnostic setting. METHODS TMA constructs from 57 cases of breast cancer were evaluated for HER2 (by ICC and FISH) by two centres. The results were compared. RESULTS There was a high level of concordance ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Breast Cancer Research
سال: 2001
ISSN: 1465-542X
DOI: 10.1186/bcr-2001-68443